VP Regulatory Affairs Rizwana F Sproule sold $431K of Kite Pharma, Inc.

Sold$431,279

$45.08Price

9,567Shares

−52%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Wed, Feb 17. Filed Fri, Feb 19, 11:13 AM ET, during the session. Not investment advice.